Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Vital Therapies Inc (NASDAQ:VTL)

3.10
Delayed Data
As of 11:04am ET
 +0.05 / +1.64%
Today’s Change
2.55
Today|||52-Week Range
8.38
-28.74%
Year-to-Date
No recent news for Vital Therapies Inc.

Today’s Trading

Previous close3.05
Today’s open3.10
Day’s range3.08 - 3.15
Volume40,460
Average volume (3 months)96,504
Market cap$128.7M
Dividend yield--
Data as of 11:04am ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)+36.71%
Earnings growth (this year)-24.17%
Earnings growth (next 5 years)+15.51%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
ORMPOramed Pharmaceutica...+0.30+3.60%
VVUSVIVUS Inc+0.02+2.31%
GEMPGemphire Therapeutic...-0.14-1.39%
CPIXCumberland Pharmaceu...+0.02+0.29%
Data as of 11:09am ET, 05/23/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$0.00
Annual profit (last year)-$41.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Co-Chairman &
Chief Executive Officer
Terence E. Winters
President
Duane D. Nash
Corporate headquarters
San Diego, California

Forecasts